Evidence method
Level · gp.fundamentals.capex_revenue_ratio
274.61% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Jun 30, 2024
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-035248General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-409.20% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-27.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1276.17% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
558.88% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
242.82% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 242.52%
- Current
- 274.61%
- Delta
- 32.10%
- Previous
- -419.01%
- Current
- -409.20%
- Delta
- 9.80%
- Previous
- -18.36%
- Current
- -27.18%
- Delta
- -8.82%
- Previous
- -551.48%
- Current
- -1276.17%
- Delta
- -724.69%
- Previous
- 394.69%
- Current
- 558.88%
- Delta
- 164.20%
- Previous
- 174.89%
- Current
- 242.82%
- Delta
- 67.93%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Analogous To · ABCL state analogue 5 →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_INCREASED →Transitioned To · ABCL CASH_GENERATION_INCREASED →Transitioned To · ABCL GROWTH_DECREASED →Transitioned To · ABCL PROFITABILITY_DECREASED →Transitioned To · ABCL R_AND_D_INTENSITY_INCREASED →Transitioned To · ABCL SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.